Growth Opportunities Act: How to benefit from the enlarged research funding 

In addition to a general overview, our new overworked brochure “Research Allowance Act”
focuses on the expansion and improvement of the research allowance under the Growth Opportunities Act:

• Increase in the assessment basis for eligible expenditure from EUR 4 million to EUR 10 million per year
• First time pro-rata acquisition and production costs for plant and equipment required in R&D projects are eligible for funding
• Increase in the funding rate from 25% to 35% for SMEs
• Increase in the annual research allowance to a maximum of EUR 3.5 million for SMEs and EUR 2.5 million for large companies
• Additional liquidity benefits by reducing advance payments on income and corporation income tax

As you would expect from an interdisciplinary consultancy such as Baker Tilly, we will advise you not only during the application process, but also, for example, in the run-up to the application on issues relating to contract research within company groups. This ensures that an application for a research allowance is successful.

At the interface to technical issues, we work successfully with innoscripta GmbH, an international software company specialized in cloud-based research and development software, which has many years of experience in the field of R&D.

Download PDF ==>

Baker Tilly implementation partner innoscripta GmbH
At the interface of technology, taxes and law, we work successfully with innoscripta GmbH, an international software company with a focus on cloud-based research and development software that has many years of experience in the field of R&D. 

Contact:
Frederik Erber, M.Sc. Partner Innoscripta
T +49 89 255553598
erber@innoscripta.com